Ledger.Open graph →
SEC Form D · filed May 8, 2020

Atsena Therapeutics, Inc

Offering
$8.1M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sanford Boye · Durham, NCExecMichael Dial · Durham, NCDirectorShannon Boye · Durham, NCExec · DirectorBenjamin Yerxa · Durham, NCDirectorPatrick Ritschel · Durham, NCExec · DirectorEmily W. Fairbairn · Foster City, CADirectorAnkur W. Desai · El Segundo, CAExec · DirectorRichard W. Libretti · Morristown, NJExec · DirectorKeith W. Archer · Foster City, CADirectorDaniel W. Landry · El Segundo, CAExecHemant Y. Taneja · Cambridge, MAExecHirsh B. Hirsh · Blacklick, OHDirectorEli Blee-Goldman · Milwaukee, WIDirectorJohn Zeratsky · Milwaukee, WIExec · DirectorHoward Hall · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗